Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Arcturus Therapeutics ARCT in the last three months. The table below summarizes their recent ...

Complex factions, Protoss, Zerg, and Terran with unique individuals, motivations, and struggles drive StarCraft 2's rich story. Iconic characters like Tychus Findlay, Zagara, and Selendis play key ...

HC Wainwright reaffirmed a “buy” rating and issued a $63.00 price objective on shares of Arcturus Therapeutics in a research note on Monday, January 13th. Cantor Fitzgerald reiterated an ...

Arcturus is advancing its vaccine and rare disease pipeline with significant developments. The initiation of a BARDA-funded Phase 1 study for bird flu, along with ongoing studies in cystic ...

Crest, Colgate Lawsuits Target Fluoride in Kids' Toothpaste, Mouth Rinse By Jonathan Stempel (Reuters) -Procter & Gamble and Colgate-Palmolive are among the defendants in six new lawsuits ...

Crest Nicholson is pushing-back publication of its latest results following a request from its auditors for more time to confirm historic building fire safety costs. The delay is for “additional ...

The color of one Kid's Crest product is shown changing to pink from blue as children brush. Fluoride helps prevent cavities when applied topically to the teeth, but when ingested can pose ...

Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy recommendation. As of December 23, 2024, the average one-year price ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...